Suppr超能文献

1 型糖尿病中的抗胰岛素三聚体复合物。

The anti-insulin trimolecular complex in type 1 diabetes.

机构信息

Barbara Davis Center for Childhood Diabetes, University of Colorado Denver, Aurora, Colorado 80045, USA.

出版信息

Curr Opin Endocrinol Diabetes Obes. 2010 Aug;17(4):329-34. doi: 10.1097/MED.0b013e32833aba41.

Abstract

PURPOSE OF REVIEW

Description of the immunologic components needed for autoimmune diabetes.

RECENT FINDINGS

The major histocompatability complex (MHC) class II molecules are the primary susceptibility genes for many autoimmune diseases, including type 1 diabetes. Understanding of the structural interaction between MHC molecules, antigenic peptides, and T-cell receptors (the three components of the trimolecular complex) has increased greatly over the past several years. The components of the anti-insulin trimolecular complex and findings that insulin is a key autoantigen in type 1 diabetes are reviewed.

SUMMARY

The anti-insulin trimolecular complex is well defined in the nonobese diabetic mouse model. Insulin and specifically, the amino acid sequence 9 to 23 of the insulin B chain, represents a primary antigenic target for islet autoimmunity in the nonobese diabetic mouse model of type 1 diabetes with a specific mutation of this peptide preventing all diabetes. Initial studies suggest the human homologs of the anti-insulin trimolecular complex may be relevant in human disease.

摘要

目的综述

描述自身免疫性糖尿病所需要的免疫成分。

最近的发现

主要组织相容性复合体(MHC)Ⅱ类分子是许多自身免疫性疾病(包括 1 型糖尿病)的主要易感基因。过去几年中,人们对 MHC 分子、抗原肽和 T 细胞受体(三分子复合物的三个组成部分)之间的结构相互作用有了很大的了解。本文综述了抗胰岛素三分子复合物的组成以及胰岛素是 1 型糖尿病关键自身抗原的发现。

总结

在非肥胖型糖尿病小鼠模型中,抗胰岛素三分子复合物得到了很好的定义。胰岛素,特别是胰岛素 B 链 9 至 23 个氨基酸序列,代表了 1 型糖尿病非肥胖型糖尿病小鼠模型中胰岛自身免疫的主要抗原性靶标,该肽段的特定突变可预防所有糖尿病。初步研究表明,抗胰岛素三分子复合物的人类同源物可能与人类疾病有关。

相似文献

1
The anti-insulin trimolecular complex in type 1 diabetes.
Curr Opin Endocrinol Diabetes Obes. 2010 Aug;17(4):329-34. doi: 10.1097/MED.0b013e32833aba41.
2
Targeting the trimolecular complex.
Clin Immunol. 2013 Dec;149(3):339-44. doi: 10.1016/j.clim.2013.02.020. Epub 2013 Mar 5.
3
Type 1 diabetes: primary antigen/peptide/register/trimolecular complex.
Immunol Res. 2013 Mar;55(1-3):270-6. doi: 10.1007/s12026-012-8367-6.
4
Autoimmune diabetes: the role of T cells, MHC molecules and autoantigens.
Autoimmunity. 1998;27(3):159-77. doi: 10.3109/08916939809003864.
5
Targeting the trimolecular complex: the pathway towards type 1 diabetes prevention.
Diabetes Technol Ther. 2013 Jun;15 Suppl 2(Suppl 2):S2-8-S2-12. doi: 10.1089/dia.2013.0114.
6
Molecular Interactions Governing Autoantigen Presentation in Type 1 Diabetes.
Curr Diab Rep. 2015 Dec;15(12):113. doi: 10.1007/s11892-015-0689-z.
7
Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice.
Nature. 2005 May 12;435(7039):220-3. doi: 10.1038/nature03523.
8
Insulin autoimmunity: prediction/precipitation/prevention type 1A diabetes.
Autoimmun Rev. 2002 May;1(3):139-45. doi: 10.1016/s1568-9972(02)00035-6.

引用本文的文献

1
Regulatory T cells targeting a pathogenic MHC class II: Insulin peptide epitope postpone spontaneous autoimmune diabetes.
Front Immunol. 2023 Aug 1;14:1207108. doi: 10.3389/fimmu.2023.1207108. eCollection 2023.
2
Molecular Interactions Governing Autoantigen Presentation in Type 1 Diabetes.
Curr Diab Rep. 2015 Dec;15(12):113. doi: 10.1007/s11892-015-0689-z.
3
Prediction and prevention of type 1 diabetes: update on success of prediction and struggles at prevention.
Pediatr Diabetes. 2015 Nov;16(7):465-84. doi: 10.1111/pedi.12299. Epub 2015 Jul 23.
4
Type 1 diabetes: A predictable disease.
World J Diabetes. 2015 Apr 15;6(3):380-90. doi: 10.4239/wjd.v6.i3.380.
5
Monoclonal antibody blocking the recognition of an insulin peptide-MHC complex modulates type 1 diabetes.
Proc Natl Acad Sci U S A. 2014 Feb 18;111(7):2656-61. doi: 10.1073/pnas.1323436111. Epub 2014 Feb 3.
7
Risk factors and primary prevention trials for type 1 diabetes.
Int J Biol Sci. 2013 Jul 18;9(7):666-79. doi: 10.7150/ijbs.6610. Print 2013.
8
Targeting the trimolecular complex: the pathway towards type 1 diabetes prevention.
Diabetes Technol Ther. 2013 Jun;15 Suppl 2(Suppl 2):S2-8-S2-12. doi: 10.1089/dia.2013.0114.
9
The Missing Heritability in T1D and Potential New Targets for Prevention.
J Diabetes Res. 2013;2013:737485. doi: 10.1155/2013/737485. Epub 2013 Mar 13.
10
Targeting the trimolecular complex.
Clin Immunol. 2013 Dec;149(3):339-44. doi: 10.1016/j.clim.2013.02.020. Epub 2013 Mar 5.

本文引用的文献

2
Chromogranin A is an autoantigen in type 1 diabetes.
Nat Immunol. 2010 Mar;11(3):225-31. doi: 10.1038/ni.1844. Epub 2010 Feb 7.
3
Ins2 deficiency augments spontaneous HLA-A*0201-restricted T cell responses to insulin.
J Immunol. 2010 Jan 15;184(2):658-65. doi: 10.4049/jimmunol.0903414. Epub 2009 Dec 4.
4
beta cell-specific CD4+ T cell clonotypes in peripheral blood and the pancreatic islets are distinct.
J Immunol. 2009 Dec 1;183(11):7585-91. doi: 10.4049/jimmunol.0901587. Epub 2009 Nov 16.
5
T cell islet accumulation in type 1 diabetes is a tightly regulated, cell-autonomous event.
Immunity. 2009 Oct 16;31(4):643-53. doi: 10.1016/j.immuni.2009.07.008. Epub 2009 Oct 8.
6
Thymus-specific deletion of insulin induces autoimmune diabetes.
EMBO J. 2009 Sep 16;28(18):2812-24. doi: 10.1038/emboj.2009.212. Epub 2009 Aug 13.
8
Restricted autoantigen recognition associated with deletional and adaptive regulatory mechanisms.
J Immunol. 2009 Jul 1;183(1):59-65. doi: 10.4049/jimmunol.0804046. Epub 2009 Jun 17.
9
The A-chain of insulin is a hot-spot for CD4+ T cell epitopes in human type 1 diabetes.
Clin Exp Immunol. 2009 May;156(2):226-31. doi: 10.1111/j.1365-2249.2009.03907.x. Epub 2009 Mar 9.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验